相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hematopoietic stem cell transplantation for multiple myeloma beyond 2010
Joan Blade et al.
BLOOD (2010)
Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple Myeloma
Heinz Ludwig et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Bortezomib As Induction Before Autologous Transplantation, Followed by Lenalidomide As Consolidation-Maintenance in Untreated Multiple Myeloma Patients
Antonio Palumbo et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma
Jean-Luc Harousseau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis
Shaji K. Kumar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2008)
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial
Thierry Facon et al.
LANCET (2007)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma
M. H. Qazilbash et al.
BONE MARROW TRANSPLANTATION (2007)
Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation
Ichiro Hanamura et al.
BLOOD (2006)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (≥65 years) myeloma patients:: comparison with younger patients treated on the same protocol
E Jantunen et al.
BONE MARROW TRANSPLANTATION (2006)
Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial
A Palumbo et al.
BLOOD (2004)
Clinical and biologic implications of recurrent genomic aberrations in myeloma
R Fonseca et al.
BLOOD (2003)
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
JA Child et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years
A Badros et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
The role of autologous transplantation in patients with multiple myeloma aged 65 years and over
B Sirohi et al.
BONE MARROW TRANSPLANTATION (2000)
分享论文
